8-K: Dynatronics Reports Q3 Fiscal 2024 Results, Revenue Guidance Lowered

Dynatronics reported a net loss of $0.9 million for Q3 fiscal year 2024, with net sales of $7.7 million, and lowered its full-year revenue guidance.

Summary

• Dynatronics reported a net loss attributable to common stockholders of $0.9 million for the third quarter of fiscal year 2024, compared to a $1.4 million loss in the same period last year.
• Net sales for the quarter were $7.7 million, down from $9.2 million in the prior year's third quarter.
• The company's gross profit margin was 23.7%, slightly down from 23.9% in the same quarter last year.
• Selling, general, and administrative expenses decreased by $1 million to $2.4 million for the quarter.
• Dynatronics has revised its full-year revenue guidance to $32.5 million to $34 million, down from previous expectations.
• The company's net cash position remained stable at $0.6 million as of March 31, 2024.
• A $2.4 million balance was drawn on a working capital asset-based line of credit, with an additional $1.9 million available.
• The company used the line of credit to reduce accounts payable and accrued expenses by $1.7 million and fund $0.4 million of prepaid expenses.

Sentiment

Score: 4

Explanation: The sentiment is negative due to decreased sales, lowered revenue guidance, and ongoing economic challenges. However, cost reductions and new product launches provide some positive aspects.

Positives

• The net loss decreased to $0.9 million from $1.4 million year-over-year.
• Selling, general, and administrative expenses were reduced by $1 million.
• The company introduced three new product lines with positive customer feedback.
• The company has a stable net cash position of $0.6 million.
• The company has an additional $1.9 million available on its line of credit.

Negatives

• Net sales decreased to $7.7 million from $9.2 million year-over-year.
• The company lowered its full-year revenue guidance to $32.5 million to $34 million.
• Gross profit margin decreased slightly to 23.7% from 23.9% year-over-year.
• The company experienced a decrease in demand in the rehabilitation space and changes to private label customer relationships.

Risks

• The company faces challenges related to the broader economic environment, including competitive pressures, inflationary pressures, and supply chain disruptions.
• There is ongoing volatility expected from the company's business optimization efforts.
• The company is experiencing slower demand in the rehabilitation space.
• Changes to private label customer relationships are impacting revenue.
• The company is not providing gross margin guidance due to reduced revenue expectations.

Future Outlook

The company expects continued volatility due to economic challenges and business optimization efforts, and anticipates SG&A to be in the range of 30% to 32% of net sales for the fiscal year. They are focused on strengthening customer relationships and improving operating profitability.

Management Comments

• We continue to make progress on achieving our sales goals and finding our path to positive EBITDA.
• We worked closely with our customers and key distributors to design three new additions to our rehabilitation furniture line.
• While it is too early to estimate the level of revenue contribution from these new product lines, we are optimistic that they will enhance our existing sales base.
• Our focus for the current fiscal year is to strengthen our customer relationships as we improve our operating profitability and financial flexibility.

Industry Context

The medical device industry is facing challenges such as supply chain disruptions and inflationary pressures, which are impacting Dynatronics' performance. The company's focus on new product lines and cost reductions is a common strategy in this environment to maintain competitiveness.

Comparison to Industry Standards

• Dynatronics' revenue decline of approximately 16% year-over-year is concerning, as many medical device companies are experiencing growth or stable revenues.
• Companies like DJO Global and Patterson Medical, which also operate in the rehabilitation and physical therapy space, have shown more resilience in their recent financial reports.
• The gross profit margin of 23.7% is relatively low compared to industry averages, which often range from 30% to 50% for medical device manufacturers.
• The reduction in SG&A expenses is a positive step, but the company needs to demonstrate improved sales performance to achieve sustainable profitability.
• The company's reliance on a line of credit to manage cash flow indicates potential financial strain compared to companies with stronger cash reserves.

Stakeholder Impact

• Shareholders will be concerned about the decreased revenue and lowered guidance.
• Employees may be affected by ongoing cost reduction efforts.
• Customers may benefit from the new product lines.
• Suppliers may be impacted by changes in the company's financial performance.
• Creditors will be monitoring the company's use of its line of credit.

Next Steps

• The company will continue to focus on strengthening customer relationships.
• The company will continue to improve operating profitability and financial flexibility.
• The company will monitor the performance of its new product lines.
• The company will seek improved stabilization in the business before considering reinstituting gross margin guidance.

Key Dates

Keywords

Dynatronics, financial results, net sales, gross profit, net loss, revenue guidance, medical devices, rehabilitation, athletic training, physical therapy